News

COVID is once again climbing to troubling levels in California — a worrying trend as health officials attempt to navigate a ...
Robert Kennedy Jr. signs recommendation eliminating mercury-based thimerosal from influenza vaccines, fulfilling anti-vaccine advocacy despite FDA safety data.
The U.S. FDA has suspended the license for Valneva’s chikungunya vaccine Ixchiq after reports of severe side effects, ...
The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq ...
A bill package proposes requiring vaccines to be covered by private insurance and Medicaid in Pennsylvania. The bills, ...
According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...
There have been 4 new reports of serious adverse events related to Ixchiq based on updated Vaccine Adverse Event Reporting System data.
Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at ...
Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...
Valneva shares dropped after it said it will no longer be able to sell its chikungunya vaccine in the U.S. after reports linked the vaccine to adverse effects. Shares trading in New York were nearly ...
The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...
Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...